Replies to post #3116 on VistaGen Therapeutics Inc (VTGN)

[clearmont88]

Of course it went well - why wouldn't it

AV-101 is afabulous asset that is not yet being properly valued - to say the least

[skidoo31]

Over half a million $$$ trade volume before open, I'm thinking the fade will be "short" lived. Looking for a nice increase in share price by end of day ;)

[zalicuslicious]

I thought that the presentation was graphically very well done, but was disappointed with some of the timelines. I thought NIH would have been 1Q, not 1H. And, I thought the first patient dose would be sooner as well. In the biotech world the timeframes usually get pushed farther out and I guess that's to be expected with the development of the process.